Taking Linagliptin May Protect Kidney Function


By: Mari Gold

Taking linagliptin seems to help protect the kidneys in people with type 2 diabetes. The drug, usually used along with diet, exercise, and sometimes other medications, lowers blood sugar levels by increasing the amounts of certain natural substances in the blood.

The executive medical director of Boehringer Ingelheim, the company that manufactures Tradjenta, the brand name for which linagliptin is the generic, reported that findings from a

group of studies showed that Tradjenta users were 16 percent less likely to reach end stage renal disease than patients taking a placebo.

According to Maximilian von Eynatten, MD, of Boehringer Ingelheim, the results wer surprising. However, George Bakris, MD, professor of medicine and director of the
Comprehensive Hypertension Center at the University of Chicago Medical School, who was not involved in the study, was not surprised at the results.

Bakris said that one key to lowering the risk of renal disease is maintaining glucose control. Since the drug assists in that goal, it can be considered a help in avoiding kidney failure.

Source: Medscape Medical News



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.